• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DHX9解旋酶初步筛选检测方法的建立

Establishment of a Primary Screening Assay for the DHX9 Helicase.

作者信息

Cencic Regina, Senechal Patrick, Pelletier Jerry

机构信息

Rm 810, 3655 Promenade Sir William Osler., McIntyre Medical Sciences Building, Montreal, Quebec, H3G 1Y6, Canada.

出版信息

Comb Chem High Throughput Screen. 2015;18(9):855-61. doi: 10.2174/1386207318666151019093433.

DOI:10.2174/1386207318666151019093433
PMID:26477352
Abstract

The RNA helicase DHX9 is an ATP-dependent DExH box helicase that can unwind DNA and RNA. Much evidence has implicated DHX9 at multiple levels of gene expression regulation ranging from genome stability and replication, to transcriptional control and translation regulation. Its association with the EWS-FLI1 fusion product, as well as the finding that its suppression can be synthetic lethal with the BCL-2 family inhibitor ABT-737 indicates a potential role in tumor maintenance. Hence, to identify small molecules that could interfere with its activity, we developed a homogenous RNA-dependent ATPase assay. We show that aurintricarboxylic acid, a promiscuous protein-nucleic acid inhibitor prevents DHX9-mediated hydrolysis demonstrating that the assay is also capable of detecting compounds that impinge on DHX9:RNA association.

摘要

RNA解旋酶DHX9是一种依赖ATP的DExH盒解旋酶,能够解开DNA和RNA。大量证据表明,DHX9在基因表达调控的多个层面发挥作用,范围从基因组稳定性和复制,到转录控制和翻译调控。它与EWS-FLI1融合产物相关联,并且其抑制作用与BCL-2家族抑制剂ABT-737具有合成致死性这一发现表明它在肿瘤维持中具有潜在作用。因此,为了鉴定能够干扰其活性的小分子,我们开发了一种均相RNA依赖性ATP酶检测方法。我们发现,金精三羧酸这种混杂的蛋白质-核酸抑制剂可阻止DHX9介导的水解反应,这表明该检测方法也能够检测影响DHX9与RNA结合的化合物。

相似文献

1
Establishment of a Primary Screening Assay for the DHX9 Helicase.DHX9解旋酶初步筛选检测方法的建立
Comb Chem High Throughput Screen. 2015;18(9):855-61. doi: 10.2174/1386207318666151019093433.
2
The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.宿主 DHX9 DExH-Box 解旋酶被招募到基孔肯雅病毒复制复合物中以进行最佳基因组 RNA 翻译。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01764-18. Print 2019 Feb 15.
3
RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.RNA解旋酶A的活性受到致癌转录因子EWS-FLI1的抑制。
Nucleic Acids Res. 2015 Jan;43(2):1069-80. doi: 10.1093/nar/gku1328. Epub 2015 Jan 6.
4
Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9.人类核孔蛋白98调节DEAH/D盒解旋酶DHX9的定位和活性。
Elife. 2017 Feb 21;6:e18825. doi: 10.7554/eLife.18825.
5
Development of assays to support identification and characterization of modulators of DExH-box helicase DHX9.开发用于支持鉴定和表征 DEAH-box 解旋酶 DHX9 调节剂的测定法。
SLAS Discov. 2023 Dec;28(8):376-384. doi: 10.1016/j.slasd.2023.08.006. Epub 2023 Aug 23.
6
Suppression of the DHX9 helicase induces premature senescence in human diploid fibroblasts in a p53-dependent manner.抑制DHX9解旋酶会以p53依赖的方式诱导人二倍体成纤维细胞过早衰老。
J Biol Chem. 2014 Aug 15;289(33):22798-22814. doi: 10.1074/jbc.M114.568535. Epub 2014 Jul 2.
7
Dependence of p53-deficient cells on the DHX9 DExH-box helicase.p53缺陷细胞对DHX9 DExH盒解旋酶的依赖性。
Oncotarget. 2017 May 9;8(19):30908-30921. doi: 10.18632/oncotarget.15889.
8
The biology of DHX9 and its potential as a therapeutic target.DHX9的生物学特性及其作为治疗靶点的潜力。
Oncotarget. 2016 Jul 5;7(27):42716-42739. doi: 10.18632/oncotarget.8446.
9
Tumor cell survival dependence on the DHX9 DExH-box helicase.肿瘤细胞存活对DHX9解旋酶(DExH盒解旋酶)的依赖性。
Oncogene. 2016 Sep 29;35(39):5093-105. doi: 10.1038/onc.2016.52. Epub 2016 Mar 14.
10
Crystal structure of human RNA helicase A (DHX9): structural basis for unselective nucleotide base binding in a DEAD-box variant protein.人 RNA 解旋酶 A(DHX9)的晶体结构:DEAD-box 变体蛋白中非选择性核苷酸碱基结合的结构基础。
J Mol Biol. 2010 Jul 23;400(4):768-82. doi: 10.1016/j.jmb.2010.05.046. Epub 2010 May 25.

引用本文的文献

1
High throughput screening for SARS-CoV-2 helicase inhibitors.高通量筛选 SARS-CoV-2 解旋酶抑制剂。
SLAS Discov. 2024 Sep;29(6):100180. doi: 10.1016/j.slasd.2024.100180. Epub 2024 Aug 22.
2
Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy.DEAD/H-box解旋酶的合成致死相互作用作为癌症治疗的靶点
Front Oncol. 2023 Jan 26;12:1087989. doi: 10.3389/fonc.2022.1087989. eCollection 2022.
3
Suppression of Transposable Elements in Leukemic Stem Cells.白血病干细胞中转座元件的抑制。
Sci Rep. 2017 Aug 1;7(1):7029. doi: 10.1038/s41598-017-07356-9.
4
The biology of DHX9 and its potential as a therapeutic target.DHX9的生物学特性及其作为治疗靶点的潜力。
Oncotarget. 2016 Jul 5;7(27):42716-42739. doi: 10.18632/oncotarget.8446.